Fecal Incontinence

Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury

Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence

Controlling Anal Incontinence by Performing Anal Exercises With Biofeedback or Loperamide (CAPABLe)

Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence

A Prospective, Multi-center, Randomized, Blinded Study to Evaluate Durasphere FI for the Treatment of Fecal Incontinence

Autologous Cell Therapy for Treatment of Fecal Incontinence

Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence

Implantation of BioSphincter TM for Treatment of Severe Passive Fecal Incontinence

Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence

Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in Elderly Subjects

Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of 7.5, 10, 12.5 or 15 mg NRL001 in a 2 g Suppository for 14 Days

Study to Investigate Safety and Response to 1 or 2 g Rectal Suppositories Containing 5 or 10 mg NRL001.

Effect of Single Doses of 10 mg NRL001 Applied as a Suppository to the Anal Canal or Rectum

Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence

Neuromodulation for Accidental Bowel Leakage

French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence

Behavioral Therapy Of Obstetric Sphincter Tears

Treatment of Faecal Incontinence With Sacral Nerve Stimulation - Improved Function With Stimulation Bilaterally?

Adaptive Behaviors Among Women With Bowel Incontinence: The ABBI Trial

A Feasibility Study of a Fecal Incontinence Management System for Medical Use

Study to Evaluate Solesta for Treatment of Fecal Incontinence

A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence